OTC Drug and Dietary Supplement Market is expected to reach US$ 4,92,102.49 million by 2027

OTC Drug and Dietary Supplement Market for Analgesics and Cough and Cold Productsto Grow at Highest CAGR During 2020–2027

According to our new market research study on “OTC drug and dietary supplement Market to 2027 – Global Analysis and Forecast – by Product, Type, Form, Distribution Channel” the market is expected to reach US$ 4,92,102.49 million by 2027 from US$ 2,93,255.40 million in 2019. The market is estimated to grow with a CAGR of 6.8 % from 2020 to 2027. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth.

Based on the product, the OTC drug and dietary supplement market is segmented into the analgesics, cough and cold products, vitamins and dietary supplements, gastrointestinal products, antacids, ophthalmic products, sleep aids, oral care products, feminine care, and others. In 2019, the analgesics segment accounted for the highest share of the market. The growth of the segment is attributed to the  highest sale of generic painkillers across the world. The sales of analgesics are widely made for acute and chronic pains. It does not require a prescription and easily available through different distribution channels. Additionally, the segment has received several product approvals in the market.

GlaxoSmithKline plc.; Sanofi; Johnson and Johnson Services, Inc.; Abbott; AbbVie Inc.; Bausch Health Companies Inc.; Bayer AG; Procter & Gamble; Novartis AG;and Reckitt Benckiser Group Plc.are among the leading companies operating in the OTC drug and dietary supplement market.

OTC Drug and Dietary Supplement Market, by Region, 2019 (%)

---

OTC Drug and Dietary Supplement Market 2027 by Product, Type, Form, Distribution Channel and Geography | The Insight Partners

Download Free Sample

---

OTC Drug and Dietary Supplement Market Forecasts to 2027 - Covid-19 Impact & Global Analysis by Product (Cough and Cold Products, Vitamins and Dietary Supplements, Analgesics, Gastrointestinal Products, Sleep Aids, Oral Care Products, Ophthalmic Products, Antacids, Feminine Care, and Others); Type (Branded and Generic); Form (Tablets, Capsules, Powders, Ointments, Liquid, and Others); Distribution Channel (Hospital and Retail Pharmacies, Retail Stores, Online Channels, and Others), and Geography

The report segments global OTC drug and dietary supplement market as follows:

By Product

• Cough and Cold Products
• Vitamins and Dietary Supplements
• Analgesics
• Gastrointestinal Products
• Sleep Aids
• Oral Care Products
• Ophthalmic Products
• Antacids
• Feminine Care
• Others

By Type

• Branded
• Generic

By Form          

• Tablets
• Capsules
• Powders
• Ointments
• Liquid
• Others

By Distribution Channel

• Hospital and Retail Pharmacies
• Retail Stores
• Online Channels
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • UK
  • Spain
  • Italy
• Asia Pacific (APAC)
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Middle East and Africa (MEA)
  • Saudi Arabia
  • UAE
  • South Africa
• South and Central America (SCAM)
  • Brazil
  • Argentina